Zobrazeno 1 - 10 of 778 pro vyhledávání: '"Ulloa-Montoya F"'
2
Akademický článek
A detailed analysis of possible efficacy signals of NTHi-Mcat vaccine against severe COPD exacerbations in a previously reported randomised phase 2b trial.
Autor: Arora AK; GSK, Via Fiorentina 1, Siena 53100, Italy. Electronic address: ashwani.k.arora@gsk.com., Chinsky K; Allegheny Health Network, Erie, PA, USA., Keller C; Studienzentrum Dr. Keller, Usinger Str. 5 60389, Frankfurt am Main, Germany., Mayers I; Department of Medicine, University of Alberta, Edmonton, AB, Canada., Pascual-Guardia S; Respiratory Department, Hospital del Mar-IMIM, CEXS, CIBERES, Barcelona, Spain., Vera MP; ABS La Roca del Vallès, Barcelona, Spain., Lambert C; GSK, Rue de l'Institut 89, Rixensart 1330, Belgium., Lombardi S; GSK, Via Fiorentina 1, Siena 53100, Italy., Rondini S; GSK, Via Fiorentina 1, Siena 53100, Italy., Tian S; GSK, Rue de l'Institut 89, Rixensart 1330, Belgium., Ulloa-Montoya F; GSK, Rue de l'Institut 89, Rixensart 1330, Belgium., Moraschini L; GSK, Via Fiorentina 1, Siena 53100, Italy., Casula D; GSK, Via Fiorentina 1, Siena 53100, Italy.
Publikováno v: Vaccine [Vaccine] 2022 Sep 29; Vol. 40 (41), pp. 5924-5932. Date of Electronic Publication: 2022 Sep 06.
Zobrazit plný text záznamu
3
Akademický článek
Subclass and avidity of circumsporozoite protein specific antibodies associate with protection status against malaria infection.
Autor: Seaton KE; Duke Human Vaccine Institute, Durham, NC, USA. kelly.seaton@duke.edu.; Duke Center for Human Systems Immunology, Durham, NC, USA. kelly.seaton@duke.edu.; Duke University Department of Surgery, Durham, NC, USA. kelly.seaton@duke.edu., Spreng RL; Duke Human Vaccine Institute, Durham, NC, USA. rachel.spreng@duke.edu.; Duke Center for Human Systems Immunology, Durham, NC, USA. rachel.spreng@duke.edu., Abraha M; Duke Human Vaccine Institute, Durham, NC, USA.; Duke Center for Human Systems Immunology, Durham, NC, USA.; Duke University Department of Surgery, Durham, NC, USA., Reichartz M; Duke Human Vaccine Institute, Durham, NC, USA.; Duke Center for Human Systems Immunology, Durham, NC, USA.; Duke University Department of Surgery, Durham, NC, USA., Rojas M; Duke Human Vaccine Institute, Durham, NC, USA., Feely F 2nd; Duke Human Vaccine Institute, Durham, NC, USA.; Duke Center for Human Systems Immunology, Durham, NC, USA.; Duke University Department of Surgery, Durham, NC, USA., Huntwork RHC; Duke Human Vaccine Institute, Durham, NC, USA.; Duke Center for Human Systems Immunology, Durham, NC, USA.; Duke University Department of Surgery, Durham, NC, USA., Dutta S; Walter Reed Army Institute of Research, Silver Spring, MD, USA., Mudrak SV; Duke Human Vaccine Institute, Durham, NC, USA.; Duke Center for Human Systems Immunology, Durham, NC, USA.; Duke University Department of Surgery, Durham, NC, USA., Alam SM; Duke Human Vaccine Institute, Durham, NC, USA.; Duke University Department of Pathology, Durham, NC, USA., Gregory S; PATH's Malaria Vaccine Initiative, Washington, DC, USA., Jongert E; GSK, Rixensart, Belgium., Coccia M; GSK, Rixensart, Belgium., Ulloa-Montoya F; GSK, Rixensart, Belgium., Wille-Reece U; PATH's Malaria Vaccine Initiative, Washington, DC, USA.; GSK, Rockville, MD, USA., Tomaras GD; Duke Human Vaccine Institute, Durham, NC, USA. gdt@duke.edu.; Duke Center for Human Systems Immunology, Durham, NC, USA. gdt@duke.edu.; Duke University Department of Surgery, Durham, NC, USA. gdt@duke.edu.; Duke University Department of Immunology, Durham, NC, USA. gdt@duke.edu.; Duke University Department of Molecular Genetics and Microbiology, Durham, NC, USA. gdt@duke.edu., Dennison SM; Duke Human Vaccine Institute, Durham, NC, USA. moses.sekaran@duke.edu.; Duke Center for Human Systems Immunology, Durham, NC, USA. moses.sekaran@duke.edu.; Duke University Department of Surgery, Durham, NC, USA. moses.sekaran@duke.edu.
Publikováno v: NPJ vaccines [NPJ Vaccines] 2021 Aug 30; Vol. 6 (1), pp. 110. Date of Electronic Publication: 2021 Aug 30.
Zobrazit plný text záznamu
4
Akademický článek
Comprehensive Data Integration Approach to Assess Immune Responses and Correlates of RTS,S/AS01-Mediated Protection From Malaria Infection in Controlled Human Malaria Infection Trials.
Autor: Young WC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States., Carpp LN; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States., Chaudhury S; Malaria Biologics Branch, Walter Reed Army Institute of Research, Silver Spring, MD, United States., Regules JA; Malaria Biologics Branch, Walter Reed Army Institute of Research, Silver Spring, MD, United States., Bergmann-Leitner ES; Malaria Biologics Branch, Walter Reed Army Institute of Research, Silver Spring, MD, United States., Ockenhouse C; PATH Malaria Vaccine Initiative, Washington, DC, United States., Wille-Reece U; PATH Malaria Vaccine Initiative, Washington, DC, United States., deCamp AC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States., Hughes E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States., Mahoney C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States., Pallikkuth S; Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL, United States., Pahwa S; Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL, United States., Dennison SM; Center for Human Systems Immunology, Duke University, Durham, NC, United States.; Departments of Surgery, Immunology, and Molecular Genetics and Microbiology, Duke University, Durham, NC, United States.; Duke Human Vaccine Institute, Duke University, Durham, NC, United States., Mudrak SV; Center for Human Systems Immunology, Duke University, Durham, NC, United States.; Departments of Surgery, Immunology, and Molecular Genetics and Microbiology, Duke University, Durham, NC, United States.; Duke Human Vaccine Institute, Duke University, Durham, NC, United States., Alam SM; Center for Human Systems Immunology, Duke University, Durham, NC, United States.; Duke Human Vaccine Institute, Duke University, Durham, NC, United States.; Department of Pathology, Duke University, Durham, NC, United States., Seaton KE; Center for Human Systems Immunology, Duke University, Durham, NC, United States.; Departments of Surgery, Immunology, and Molecular Genetics and Microbiology, Duke University, Durham, NC, United States.; Duke Human Vaccine Institute, Duke University, Durham, NC, United States., Spreng RL; Center for Human Systems Immunology, Duke University, Durham, NC, United States.; Departments of Surgery, Immunology, and Molecular Genetics and Microbiology, Duke University, Durham, NC, United States.; Duke Human Vaccine Institute, Duke University, Durham, NC, United States., Fallon J; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, United States., Michell A; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, United States., Ulloa-Montoya F; GSK, Rixensart, Belgium., Coccia M; GSK, Rixensart, Belgium., Jongert E; GSK, Rixensart, Belgium., Alter G; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, United States., Tomaras GD; Center for Human Systems Immunology, Duke University, Durham, NC, United States.; Departments of Surgery, Immunology, and Molecular Genetics and Microbiology, Duke University, Durham, NC, United States.; Duke Human Vaccine Institute, Duke University, Durham, NC, United States., Gottardo R; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
Publikováno v: Frontiers in big data [Front Big Data] 2021 Jun 15; Vol. 4, pp. 672460. Date of Electronic Publication: 2021 Jun 15 (Print Publication: 2021).
Zobrazit plný text záznamu
6
Akademický článek
Limited Adipogenic Differentiation Potential of Human Dental Pulp Stem Cells Compared to Human Bone Marrow Stem Cells.
Autor: Bugueno, Isaac Maximiliano1 (AUTHOR) isaac.buguenovaldebenito@zzm.uzh.ch, Alastra, Giuseppe1,2 (AUTHOR) giuseppe.alastra2@unibo.it, Balic, Anamaria1 (AUTHOR) anamaria.balic@zzm.uzh.ch, Stadlinger, Bernd3 (AUTHOR) bernd.stadlinger@zzm.uzh.ch, Mitsiadis, Thimios A.1 (AUTHOR) thimios.mitsiadis@zzm.uzh.ch
Publikováno v: International Journal of Molecular Sciences. Oct2024, Vol. 25 Issue 20, p11105. 19p.
Zobrazit plný text záznamu
7
Akademický článek
Transcriptional profiles of adjuvanted hepatitis B vaccines display variable interindividual homogeneity but a shared core signature.
Autor: De Mot L; GSK, 1330 Rixensart, Belgium., Bechtold V; GSK, 1330 Rixensart, Belgium., Bol V; GSK, 1330 Rixensart, Belgium., Callegaro A; GSK, 1330 Rixensart, Belgium., Coccia M; GSK, 1330 Rixensart, Belgium., Essaghir A; GSK, 1330 Rixensart, Belgium., Hasdemir D; Bioinformatics Laboratory, University of Amsterdam, 1012 WX Amsterdam, Netherlands.; Biosystems Data Analysis Group, University of Amsterdam, 1012 WX Amsterdam, Netherlands., Ulloa-Montoya F; GSK, 1330 Rixensart, Belgium., Siena E; GSK, 53100 Siena, Italy., Smilde A; Biosystems Data Analysis Group, University of Amsterdam, 1012 WX Amsterdam, Netherlands., van den Berg RA; GSK, Rockville, MD 20850, USA., Didierlaurent AM; GSK, 1330 Rixensart, Belgium., Burny W; GSK, 1330 Rixensart, Belgium., van der Most RG; GSK, 1330 Rixensart, Belgium. robbert.x.van-der-most@gsk.com.
Publikováno v: Science translational medicine [Sci Transl Med] 2020 Nov 11; Vol. 12 (569).
Zobrazit plný text záznamu
8
Akademický článek
A Th1/IFNγ Gene Signature Is Prognostic in the Adjuvant Setting of Resectable High-Risk Melanoma but Not in Non-Small Cell Lung Cancer.
Autor: Dizier B; GSK, Rixensart, Belgium., Callegaro A; GSK, Rixensart, Belgium., Debois M; GSK, Rixensart, Belgium., Dreno B; Department of Dermato-oncology, Hotel Dieu Nantes University Hospital, Nantes, France., Hersey P; Melanoma Immunology and Oncology Group, Centenary Institute, University of Sydney, New South Wales, Australia., Gogas HJ; Department of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Kirkwood JM; Department of Medicine and UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Vansteenkiste JF; Department of Respiratory Diseases, University Hospitals KU Leuven, Leuven, Belgium., Sequist LV; Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Atanackovic D; Oncology/Hematology/Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Goeman J; Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, the Netherlands., van Houwelingen H; Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, the Netherlands., Salceda S; Thermo Fisher Scientific, Pleasanton, California., Wang F; Thermo Fisher Scientific, Pleasanton, California., Therasse P; GSK, Rixensart, Belgium., Debruyne C; GSK, Rixensart, Belgium., Spiessens B; GSK, Rixensart, Belgium., Brichard VG; GSK, Rixensart, Belgium., Louahed J; GSK, Rixensart, Belgium., Ulloa-Montoya F; GSK, Rixensart, Belgium. fernando.x.ulloa-montoya@gsk.com.
Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Apr 01; Vol. 26 (7), pp. 1725-1735. Date of Electronic Publication: 2019 Nov 15.
Zobrazit plný text záznamu
9
Akademický článek
Investigating the role of senescence biomarkers in colorectal cancer heterogeneity by bulk and single-cell RNA sequencing.
Autor: Ding, Chengsheng1,2, Xu, Ximo1,2, Zhang, Xian3, Zhang, Enkui4, Li, Shuchun1,2, Fan, Xiaodong1,2, Ma, Junjun1,2 mjj11365@rjh.com.cn, Yang, Xiao1,2,5 yxrjmis@sjtu.edu.cn, Zang, Lu1,2 7200010848@shsmu.edu.cn
Publikováno v: Scientific Reports. 8/29/2024, Vol. 14 Issue 1, p1-20. 20p.
Zobrazit plný text záznamu
10
Akademický článek
DNA methylation profiling deciphers three EMT subtypes with distinct prognoses and therapeutic vulnerabilities in breast cancer.
Autor: Shihao Sun1, Shuang Chen2, Nan Wang1, Zehao Hong3, Yi Sun1, Yijia Xu1, Jiangrui Chi1 rebecca20110311@163.com, Xinxing Wang1 xx_wang86@163.com, Lin Li1 fcclil6@zzu.edu.cn
Publikováno v: Journal of Cancer. 2024, Vol. 15 Issue 15, p4922-4938. 17p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje